Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

Mayo Clinic

Status and phase: Enrolling; Phase 4

Conditions: Hip Arthroscopy

Treatments: Drug: Oxycodone; Drug: Acetaminophen; Drug: Methocarbamol; Drug: Gabapentin; Drug: Ibuprofen

Study type: Interventional

Funder types: Other

Identifiers

NCT05076110

21-003441

Details and patient eligibility

About

This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.

Enrollment: 188 estimated patients

Sex: All

Ages: 16 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Scheduled for a primary Hip Arthroscopy at Mayo Clinic (Rochester, MN)

Exclusion criteria

• medical history of known allergies or intolerance to allergies or intolerance to Motrin, Gabapentin, Tylenol, dexamethasone, tramadol, or Robaxin.
• Substantial alcohol or drug abuse.
• History of narcotics within 6 months of surgery.
• Pregnancy.
• Renal impairment.
• Peptic ulcer disease.
• GI bleeding.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

188 participants in 2 patient groups

Standard of Care Group

Active Comparator group

Description:

Subjects will receive standard of care pain medication Oxycodone for pain control following hip arthroscopy procedure

Treatment:

Drug: Oxycodone

Non-Opiate Pain Control Group

Experimental group

Description:

Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.

Treatment:

Drug: Ibuprofen

Drug: Gabapentin

Drug: Methocarbamol

Drug: Acetaminophen